Repeated infliximab therapy after serum sickness-like reaction in Crohn’s diseasePál Miheller, Zsolt Tulassay, Györgyi Műzes et al.|Journal of Emergency Medicine|2007Cited by 9
P621 Safety and effectiveness of vedolizumab and ustekinumab in inflammatory bowel disease patients after liver transplantation for primary sclerosing cholangitis: results from an ECCO-confer case seriesTom Holvoet, Triana Lobatón, Pál Miheller et al.|Journal of Crohn s and Colitis|2024Cited by 4
M2081 Glucocorticoid Receptor Polymorphism in Inflammatory Bowel DiseaseEmese Mihály, Zsolt Tulassay, Péter Gergics et al.|Gastroenterology|2008Cited by 0
SFRP1, SLIT2 and MAL Hypermethylated and Underexpressed in Left-Sided, CIMP-Negative Colorectal CancerÁrpád V. Patai, Béla Molnár, Orsolya Galamb et al.|Gastroenterology|2011Cited by 0
Gyulladásos bélbetegségek biológiai kezelése 2018-banPál Miheller, Zsolt Tulassay, Emese Mihály|Magyar Tudomány|2019Cited by 0